Interferon-γ and infectious diseases: Lessons and prospects
成果类型:
Review
署名作者:
Casanova, Jean-Laurent; MacMicking, John D.; Nathan, Carl F.
署名单位:
Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Cornell University; Weill Cornell Medicine
刊物名称:
SCIENCE
ISSN/ISSBN:
0036-8770
DOI:
10.1126/science.adl2016
发表日期:
2024-04-19
关键词:
human mononuclear phagocytes
bacille calmette-guerin
ifn-gamma
human macrophages
t-lymphocytes
i interferon
mycobacterial disease
transcription factor
effector mechanisms
toxoplasma-gondii
摘要:
Infectious diseases continue to claim many lives. Prevention of morbidity and mortality from these diseases would benefit not just from new medicines and vaccines but also from a better understanding of what constitutes protective immunity. Among the major immune signals that mobilize host defense against infection is interferon-gamma (IFN-gamma), a protein secreted by lymphocytes. Forty years ago, IFN-gamma was identified as a macrophage-activating factor, and, in recent years, there has been a resurgent interest in IFN-gamma biology and its role in human defense. Here we assess the current understanding of IFN-gamma, revisit its designation as an interferon, and weigh its prospects as a therapeutic against globally pervasive microbial pathogens.